• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Previous Issues
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Egyptian Journal of Histology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 48 (2025)
Issue Issue 2
Issue Issue 1
Volume Volume 47 (2024)
Volume Volume 46 (2023)
Volume Volume 45 (2022)
Volume Volume 44 (2021)
Volume Volume 43 (2020)
Volume Volume 42 (2019)
Volume Volume 41 (2018)
Volume Volume 40 (2017)
Abd El-Mouaty, H., Dwedar, F., Hassaan, P., Abouelrous, R., Nabil, I. (2025). The Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells Versus their Extracellular Vesicles on A Rat Model of Pulmonary Alveolar Injury. Histological, Biochemical and Physiological Study. Egyptian Journal of Histology, 48(2), 673-697. doi: 10.21608/ejh.2024.275296.2037
HM Abd El-Mouaty; Fatma I Dwedar; Passainte S Hassaan; Rana Ahmed Abouelrous; iman mohamed Nabil. "The Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells Versus their Extracellular Vesicles on A Rat Model of Pulmonary Alveolar Injury. Histological, Biochemical and Physiological Study". Egyptian Journal of Histology, 48, 2, 2025, 673-697. doi: 10.21608/ejh.2024.275296.2037
Abd El-Mouaty, H., Dwedar, F., Hassaan, P., Abouelrous, R., Nabil, I. (2025). 'The Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells Versus their Extracellular Vesicles on A Rat Model of Pulmonary Alveolar Injury. Histological, Biochemical and Physiological Study', Egyptian Journal of Histology, 48(2), pp. 673-697. doi: 10.21608/ejh.2024.275296.2037
Abd El-Mouaty, H., Dwedar, F., Hassaan, P., Abouelrous, R., Nabil, I. The Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells Versus their Extracellular Vesicles on A Rat Model of Pulmonary Alveolar Injury. Histological, Biochemical and Physiological Study. Egyptian Journal of Histology, 2025; 48(2): 673-697. doi: 10.21608/ejh.2024.275296.2037

The Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells Versus their Extracellular Vesicles on A Rat Model of Pulmonary Alveolar Injury. Histological, Biochemical and Physiological Study

Article 19, Volume 48, Issue 2, June 2025, Page 673-697  XML PDF (9.3 MB)
Document Type: Original Article
DOI: 10.21608/ejh.2024.275296.2037
View on SCiNiTO View on SCiNiTO
Authors
HM Abd El-Mouaty1; Fatma I Dwedar2; Passainte S Hassaan3; Rana Ahmed Abouelrous4; iman mohamed Nabil email orcid 5
1Histology and cell biology, Alexandria faculty of medicine
2Medical Biochemistry, Alexandria faculty of medicine
3Medical physiology, Alexandria faculty of medicine
4Human Anatomy and Embryology, Alexandria faculty of Medicine
5Alexandria faculty of medicine, histology and cell biology departement
Abstract
Introduction: Pulmonary alveolar injury can eventually result in pulmonary fibrosis, nevertheless, only palliative treatment is available. Bone marrow-derived mesenchymal stem cells (BM-MSCs) and their extracellular vesicles (EVs) possess antifibrotic effects.
Aim of the Work: To assess the therapeutic potential of BM-MSCs versus their EVs on bleomycin model of pulmonary alveolar injury.
Materials and Methods: 66 adult rats were used; 60 female rats for experimental groups and 6 male rats for obtainment of BM-MSCs. BM-MSCs and their derived EVs were characterized. The 60 rats were randomized equally into: control group, and other 4 groups received intratracheal instillation of bleomycin. On day 14, the rats were either sacrificed (fibrosis group; FG) or received free culture media (spontaneous recovery group; SRG); BM-MSCs (SCG) or EVs (EVG), respectively. Pulmonary function tests (PFTs) and arterial blood gases (ABG) were evaluated at the beginning and at the end of the experiment. On day 28, the body weights were recorded and the rats were sacrificed. The lungs were obtained and weighed and lung to body weight (LW/BW) were calculated. The tissue levels of transforming growth factor-beta1 (TGF-β1), vascular endothelial growth factor (VEGF), Bcl-2 Associated X-protein (BAX), malondialdehyde (MDA), the antioxidant superoxide dismutase and total antioxidant capacity were measured. The lungs were processed for light and electron microscopic examination. The thickness of the interalveolar septa and percentage area of collagen were subjected to morphometric analysis. Statistical analysis was done.
Results: Bleomycin resulted in distorted alveoli, nuclear changes affecting the alveolar cells with vacuolation, proliferation of type II pneumocytes, desquamated cells, cellular infiltration and congested blood vessels, significant increase in collagen deposition, thickness of septa, LW/BW, TGF-β, VEGF, BAX and MDA with reduction in PFTs and antioxidant enzymes with disturbed ABG. EVG revealed moderate improvement, while SCG showed better results.
Conclusion: BM-MSCs injection showed superb antifibrotic effect compared to their derived EVs.
Keywords
Bleomycin; electron microscopy; extracellular vesicles; lung fibrosis; stem cells
Statistics
Article View: 307
PDF Download: 34
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.